111482 ⎘
ssRNA viruses positive-sense; Details; Picornaviridae; Aphthovirus, e.g. footandmouth disease virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
RECOMBINANT PROTEIN COMPRISING PROTEIN DERIVED FROM FOOT-AND-MOUTH DISEASE VIRUS TYPE O CAPSID PROTEIN AND SFC PROTEIN AND USE THEREOF
#2DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA
#3T-CELL EPITOPE POLYPEPTIDE OF FOOT AND MOUTH DISEASE VIRUS AND USES THEREOF
#4RECOMBINANT BACULOVIRUSES, VACCINE COMPOSITIONS THAT COMPRISE IT, AND METHODS FOR INDUCING AN IMMUNE RESPONSE
#5FMDV VIRUS-LIKE PARTICLE WITH DOUBLE STABILIZING MUTATION
#6Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
#7FMDV VIRUS-LIKE PARTICLE WITH STABILIZING MUTATION
#8ENGINEERING PEPTIDES FOR A A VB6 INTEGRIN BINDING AND RELATED METHODS OF USE AND SYNTHESIS
#9BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF
#10BACULOVIRUS EXPRESSION VECTOR
#11FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN, VACCINE COMPOSITION, PREPARATION METHOD, AND USE THEREOF
#12Recombinant foot-and-mouth disease virus with reduced immunosuppression activity, and preparation method and use thereof
#13Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#14Recombinant virus capable of stably expressing target proteins
#15Bi-terminal pegylated integrin-binding peptides and methods of use thereof
#16UNIVERSAL VACCINE FOR VIRAL DISEASES
#17Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems
#18Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#19Method for preparing foot-and-mouth disease virus-like particles
#20FOOT AND MOUTH DISEASE VIRUS SEROTYPE O (FMDV-O) VACCINE
#21Vaccines and pharmaceutical compositions against foot-and-mouth disease virus
#22DNA vaccines against foot-and-mouth disease virus
#23Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modified FMDV 3C protease
#24Processing engineered FMDV P1 polypeptide using an alternative TEV protease
#25Universal vaccine for viral diseases
#26Stabilised FMDV capsids
#27MONOCLONAL ANTIBODY AGAINST NOVEL EPITOPES OF FOOT-AND-MOUTH DISEASE VIRUS PROTEIN 3ABC AND USES THEREOF
#28Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides, compositions, methods and systems
#29Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof
#30Bird flu vaccine combination comprising virus-like particles and novel adjuvants
#31Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof
#32Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease
#33FMDV and E2 fusion proteins and uses thereof
#34Mosaic vaccines for serotype a foot-and-mouth disease virus
#35Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof
#36Monoclonal antibody against novel epitopes of foot-and-mouth disease virus protein 3ABC and uses thereof
#37Bi-terminal pegylated integrin-binding peptides and methods of use thereof
#38Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles
#39FMDV and E2 fusion proteins and uses thereof
#40Stabilised FMDV capsids
#41Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#42Methods and compositions to protect aquatic invertebrates from disease
#43Modified foot and mouth disease virus (FMDV) VP1 capsid protein
#44Expression cassette for efficient surface display of antigenic proteins
#45Foot and mouth disease virus with increased stability and its use as vaccine
#46Method of rapidly producing improved vaccines for animals
#47Methods and compositions to protect aquatic invertebrates from disease
#48Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
#49TLR-2 agonists and methods of use thereof
#50Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#51Construct for producing empty virus capsids
#52CRE-LOX BASED GENE KNOCKDOWN CONSTRUCTS AND METHODS OF USE THEREOF
#53Methods and compositions to protect aquatic invertebrates from disease
#54METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS
#55Vaccine
#56CHIMERIC FOOT AND MOUTH DISEASE VIRUSES
#57COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION
#58REGULATED EXPRESSION OF RECOMBINANT PROTEINS FROM ADENO-ASSOCIATED VIRAL VECTORS
#59Two-component genome flavivirus and uses thereof
#60Preparation of Soluble Capsid Proteins of Picornaviruses Using SUMO Fusion Technology
#61METHODS AND COMPOUNDS FOR MITIGATING PATHOGENIC OUTBREAKS USING REPLIKIN COUNT CYCLES
#62Cre-lox based gene knockdown constructs and methods of use thereof
#63Virus-Like Particle Containing A Dengue Recombinant Replicon
#64Virus-like particle containing a Dengue virus recombinant replicon
#65Chimeric tymovirus-like particles and process thereof
#66TSG101-GAG INTERACTION AND USE THEREOF
#67VP1 of foot-and-mouth disease virus
#68Apoptosis-inducing polypeptides
#69Apoptosis-inducing polypeptides
#70Protein isolation
#71Regulated expression of recombinant proteins from adeno-associated viral vectors
#72Stabilized immunogenic HBc chimer particles
#73Nucleic acid sequences encoding proteins capable of associating into a virus-like particle
#74Novel recombinant T4 phage particle and uses thereof
#75Virus-like particle containing a dengue virus recombinant replicon
#76Immunogenic peptides of foot-and-mouth disease viruses
#77Apoptosis-inducing polypeptides
#78Protein isolation